NCT00750243View on ClinicalTrials.gov

Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

LT-NS001

1200 mg b.i.d. p.o. for 7.5 days

DRUG

Naprosyn®

500 mg b.i.d. p.o. for 7.5 days

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

Sponsors
All Listed Sponsors
lead

Logical Therapeutics

INDUSTRY

NCT00750243 - Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation | Biotech Hunter | Biotech Hunter